UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
☐ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________ to _______________________
Commission File number: 001-41432
SK
Growth Opportunities Corporation
(Exact name of registrant as specified in its charter)
Cayman Islands | | 001-41432 | | 98-1643582 |
(State or other jurisdiction of
incorporation or organization) | | (Commission File Number) | | (I.R.S. Employer
Identification Number) |
228 Park Avenue S #96693 New York, New York | | 10003 |
(Address of principal executive offices) | | (Zip Code)) |
(917) 599-1622
(Registrant’s telephone number, including area code)
Not Applicable |
(Former name or former address, if changed since last report) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-half of one redeemable warrant | | SKGRU | | The Nasdaq Stock Market LLC |
Class A Ordinary Shares | | SKGR | | The Nasdaq Stock Market LLC |
Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 | | SKGRW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405of
this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes
☒ No ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large
accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☒ |
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of May 15, 2024, there were
10,056,597 shares of the registrant’s Class A ordinary shares, par value $0.0001 per share, and 5,240,000 shares of the registrant’s
Class B ordinary shares, par value $0.0001 per share, issued and outstanding.
SK GROWTH OPPORTUNITIES CORPORATION
TABLE OF CONTENTS
PART I-FINANCIAL INFORMATION
ITEM
1. FINANCIAL STATEMENTS
SK GROWTH OPPORTUNITIES CORPORATION
CONDENSED BALANCE SHEETS
| |
March 31, 2024 | | |
December 31, 2023 | |
Assets: | |
(unaudited) | | |
| |
Current assets: | |
| | |
| |
Cash | |
$ | 536,588 | | |
$ | 163,718 | |
Prepaid expenses | |
| 165,625 | | |
| 209,750 | |
Total current assets | |
| 702,213 | | |
| 373,468 | |
| |
| | | |
| | |
Non-current assets: | |
| | | |
| | |
Investments held in Trust Account | |
| 111,000,714 | | |
| 109,573,279 | |
Total non-current assets | |
| 111,000,714 | | |
| 109,573,279 | |
Total Assets | |
$ | 111,702,927 | | |
$ | 109,946,747 | |
| |
| | | |
| | |
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 25,629 | | |
$ | 107,223 | |
Accrued expenses | |
| 2,264,556 | | |
| 1,204,161 | |
Promissory Note | |
| 1,280,000 | | |
| 380,000 | |
Total current liabilities | |
| 3,570,185 | | |
| 1,691,384 | |
| |
| | | |
| | |
Non-current liabilities: | |
| | | |
| | |
Overfunding loan | |
| 5,240,000 | | |
| 5,240,000 | |
Deferred underwriting and advisory fees | |
| 7,336,000 | | |
| 7,336,000 | |
Total non-current liabilities | |
| 12,576,000 | | |
| 12,576,000 | |
Total liabilities | |
| 16,146,185 | | |
| 14,267,384 | |
| |
| | | |
| | |
Commitments and Contingencies | |
| | | |
| | |
Class A ordinary shares, $0.0001 par value; 9,000,000,000 shares authorized; 10,056,597 shares subject to possible redemption at approximately $11.03 and $10.89 per share as of March 31, 2024 and December 31, 2023, respectively | |
| 110,900,714 | | |
| 109,473,279 | |
| |
| | | |
| | |
Shareholders’ Deficit: | |
| | | |
| | |
Preference shares, $0.0001 par value; 990,000 shares authorized; none issued or outstanding as of March 31, 2024 and December 31, 2023 | |
| — | | |
| — | |
Class A ordinary shares, $0.0001 par value; 9,000,000,000 shares authorized; no non-redeemable shares issued or outstanding as of March 31, 2024 and December 31, 2023 | |
| — | | |
| — | |
Class B ordinary shares, $0.0001 par value; 999,000,000 shares authorized; 5,240,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023 | |
| 524 | | |
| 524 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (15,344,496 | ) | |
| (13,794,440 | ) |
Total shareholders’ deficit | |
| (15,343,972 | ) | |
| (13,793,916 | ) |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | |
$ | 111,702,927 | | |
$ | 109,946,747 | |
The
accompanying notes are an integral part of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
UNAUDITED CONDENSED STATEMENTS OF
OPERATIONS
| |
For the Three Months Ended March 31, | |
| |
2024 | | |
2023 | |
General and administrative expenses | |
$ | 1,550,055 | | |
$ | 292,051 | |
Loss from operations | |
| (1,550,055 | ) | |
| (292,051 | ) |
| |
| | | |
| | |
Other income: | |
| | | |
| | |
Income from investments held in Trust Account | |
| 1,427,434 | | |
| 2,300,710 | |
Total other income | |
| 1,427,434 | | |
| 2,300,710 | |
| |
| | | |
| | |
Net income (loss) | |
$ | (122,621 | ) | |
$ | 2,008,659 | |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A ordinary shares | |
| 10,056,597 | | |
| 20,960,000 | |
Basic and diluted net income (loss) per share, Class A ordinary shares | |
$ | (0.01 | ) | |
$ | 0.08 | |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class B ordinary shares | |
| 5,240,000 | | |
| 5,240,000 | |
Basic and diluted net income (loss) per share, Class B ordinary shares | |
$ | (0.01 | ) | |
$ | 0.08 | |
The accompanying notes are an integral
part of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
UNAUDITED CONDENSED STATEMENTS OF
CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31,
2024
| |
Class B | | |
Additional | | |
| | |
Total | |
| |
Ordinary Shares | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance—December 31, 2023 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (13,794,440 | ) | |
$ | (13,793,916 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (1,427,435 | ) | |
| (1,427,435 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| (122,621 | ) | |
| (122,621 | ) |
Balance—March 31, 2024 (unaudited) | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (15,344,496 | ) | |
$ | (15,343,972 | ) |
FOR THE THREE MONTHS ENDED MARCH 31,
2023
| |
Class B | | |
Additional | | |
| | |
Total | |
| |
Ordinary Shares | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance —December 31, 2022 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (11,643,310 | ) | |
$ | (11,642,786 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (2,300,710 | ) | |
| (2,300,710 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| 2,008,659 | | |
| 2,008,659 | |
Balance — March 31, 2023 (unaudited) | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (11,935,361 | ) | |
$ | (11,934,837 | ) |
The accompanying notes are an integral
part of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
UNAUDITED CONDENSED STATEMENT OF
CASH FLOWS
| |
For the Three Months Ended March 31, | |
| |
2024 | | |
2023 | |
Cash Flows from Operating Activities: | |
| | |
| |
Net income (loss) | |
$ | (122,621 | ) | |
$ | 2,008,659 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
General and administrative expenses paid by related party under promissory note | |
| 256,000 | | |
| — | |
Income from investments held in Trust Account | |
| (1,427,434 | ) | |
| (2,300,710 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 44,125 | | |
| 53,741 | |
Accounts payable | |
| (81,594 | ) | |
| 21,698 | |
Accrued expenses | |
| 1,060,395 | | |
| 74,509 | |
Net cash used in operating activities | |
| (271,130 | ) | |
| (142,103 | ) |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Proceeds from promissory note | |
| 644,000 | | |
| — | |
Net cash provided by financing activities | |
| 644,000 | | |
| — | |
| |
| | | |
| | |
Net change in cash | |
| 372,870 | | |
| (142,103 | ) |
Cash—beginning of the period | |
| 163,718 | | |
| 515,410 | |
Cash—end of the period | |
$ | 536,588 | | |
$ | 373,307 | |
| |
| | | |
| | |
Non-cash financing activities: | |
| | | |
| | |
General and administrative expenses paid by Sponsor
under promissory note | |
$ | 256,000 | | |
$ | — | |
The
accompanying notes are an integral part of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Note 1—Description of Organization,
Business Operations, Liquidity and Basis of Presentation
SK Growth Opportunities Corporation (the “Company”)
is a blank check company incorporated in Cayman Islands on December 8, 2021. The Company was formed for the purpose of effecting
a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
As of March 31, 2024, the Company had not commenced
any operations. All activity for the period from December 8, 2021 (inception) through March 31, 2024, relates to the Company’s
formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering,
its search for a Business Combination (as defined below). The Company will not generate any operating revenues until after the completion
of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the
proceeds held in the Trust Account (as defined below).
The Company’s sponsor is Auxo
Capital Managers LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s
Initial Public Offering was declared effective on June 23, 2022. On June 28, 2022, the Company consummated its Initial Public
Offering of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the
Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering
costs of approximately $12.0 million, of which $7.0 million was for deferred underwriting commissions (see Note 5). The underwriter
was granted a 45-dayoption from the date of the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional
Units to cover over-allotments, if any, at $10.00 per Unit (the “Over-Allotment Option”). On July 20, 2022, pursuant
to the underwriter’s notice of the partial exercise of the Over-Allotment Option, the Company sold an additional 960,000 Units,
at $10.00 per Unit, generating aggregate additional gross proceeds of $9.6 million to the Company (the “Partial Over-Allotment
Exercise”). On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000
Founder Shares (as defined in Note 4).
Simultaneously with the closing of
the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,600,000 warrants of
the Company (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price
of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating proceeds of $6.6 million (see Note 4). Substantially
concurrently with the closing of the Partial Over-Allotment Exercise, the Company completed the sale of 192,000 additional Private Placement
Warrants to the Sponsor (the “Additional Private Placement”) at a purchase price of $1.00 per Private Placement Warrant, generating
gross proceeds to the Company of $192,000.
In addition, upon the consummation
of the Initial Public Offering on June 28, 2022, the Sponsor provided the Company with the First Overfunding Loan (as defined in
Note 4) in the amount of $5.0 million to deposit in the Trust Account at no interest. In connection with the Partial Over-Allotment
Exercise on July 20, 2022, the Sponsor provided the Company with the Second Overfunding Loan (as defined in Note 4) in the amount
of $240,000 to deposit in the Trust Account.
Upon
the closing of the Initial Public Offering and the Partial Over-Allotment Exercise, approximately $214.8 million
($10.25 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering, the Partial
Over-Allotment Exercise the proceeds of the Overfunding Loans and certain of the proceeds of the Private Placement and the
Additional Private Placement, was placed in a trust account (the “Trust Account”) located in the United States with
Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government
securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the
“Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting
certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest
only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a
Business Combination and (ii) the distribution of the Trust Account as described below.
The Company’s management has
broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the sale of Private Placement
Warrants and the proceeds from the Overfunding Loan, although substantially all of the net proceeds are intended to be applied generally
toward consummating a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair
market value of at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting discounts
held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business
Combination. However, the Company only intends to complete a Business Combination if the post-transaction company owns or acquires 50%
or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient
for it not to be required to register as an investment company under the Investment Company Act.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
The Company will provide the holders
of the Company’s Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their
Public Shares upon the completion of a Business Combination either (i) in connection with a shareholders meeting called to approve
the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval
of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will
be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.25 per
Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by
the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 5).
The Public Shares are recognized at
redemption value and classified as temporary equity, in accordance with the Financial Accounting Standards Board (“FASB”)
Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).
The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination.
If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons,
the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Articles of Association”),
conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file
tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is
required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem
the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally,
each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.
If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed
to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination.
In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in
connection with the completion of a Business Combination.
The Articles of Association provides
that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in
concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares included
in the Units issued in the Company’s Initial Public Offering, without the prior consent of the Company. The holders of the Founder
Shares (the “initial shareholders”) agreed not to propose an amendment to the Articles of Association (A) to modify the
substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100%
of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with
respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, unless the
Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
On
December 27, 2023, the Company held an extraordinary general meeting of shareholders (the “Extension Meeting”), to (i) amend
the Company’s amended and restated memorandum and articles of association (the “Memorandum and Articles of Association”)
to extend the date by which the Company has to consummate a business combination from December 28, 2023 to September 30, 2024
(or March 31, 2025) as the Company’s board of directors (the “Board”) may approve in accordance with the Memorandum
and Articles of Association (such amendment, the “Articles Amendment” and such proposal, the “Extension Amendment Proposal”),
(ii) amend the Investment Management Trust Agreement, dated June 23, 2022, by and between the Company and Continental, to extend
the date on which Continental must liquidate the Trust Account if the Company has not completed its initial business combination, from
December 28, 2023 to September 30, 2024 (or March 31, 2025) as the Board may approve (the “Trust Amendment Proposal”).
The Extension Amendment Proposal and the Trust Amendment Proposal were approved.
In connection with the vote to approve
the Articles Amendment, the holders of 10,903,403 Class A Ordinary Shares of the Company properly exercised their right to redeem
their shares for cash at a redemption price of approximately $10.88 per share, for an aggregate redemption amount of approximately $118,642,864.
If it is reasonably determined by the Company
and Webull (as defined below) that it may not be able to consummate the initial Business Combination by September 30, 2024, the Company
shall (a) use its reasonable best efforts to cause the board of directors to approve such amendment to the memorandum and articles
of association, as amended, to provide that the date by which the Company must consummate a business combination in accordance with the
memorandum and articles of association, as amended, is extended from September 30, 2024 to March 31, 2025 (such period by which
the Company must consummate a business combination, as amended, and as may be extended in accordance with the provisions of the Business
Combination Agreement, the “Combination Period” and such proposal, the “Extension Proposal”) and resolve to recommend
that the shareholders approve such Extension Proposal by special resolution, which is a resolution passed by a majority of at least two-thirds
of such members of the company as, being entitled to do so, vote in person or by proxy at a general meeting, and includes a unanimous
written resolution (the “Extension Recommendation”), and not change or modify or propose to change or modify the Extension
Recommendation, and (b) prepare and file with the SEC proxy statement (such proxy statement, together with any amendments or
supplements thereto, the “Extension Proxy Statement”) for the purpose of soliciting proxies from the shareholders for the
Extension Proposal, which shall include, among other things, (x) a description and introduction of Webull, and (y) a statement
that the Business Combination Agreement and any other transaction documents have been entered into. The Company shall discuss in
good faith with Webull and agree upon the terms of the Extension Proposal, including the proposed amendments to the memorandum and articles
of association and additional economic incentives, if any, to be offered to the shareholders in connection with their approval of
the Extension Proposal.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
If the
Company is unable to consummate an initial Business Combination within the Combination Period, the Company will (i) cease all
operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest
to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely
extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if
any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining
shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under
Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
The initial shareholders agreed to
waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete
a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial
Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company
fails to complete a Business Combination within the Combination Period. The underwriter agreed to waive its rights to the deferred underwriting
commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination
Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund
the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets
remaining available for distribution (including Trust Account assets) will be only $10.25. In order to protect the amounts held in the
Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s
independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business
with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the
Trust Account to below (i) $10.25 per Public Share or (ii) the lesser amount per Public Share held in the Trust Account as of the
date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of taxes payable, provided
that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access
to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In
the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent
of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent
registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements
with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Going Concern Consideration
As of March 31, 2024, the Company had
$536,588 in cash and working capital deficit of approximately $2.9 million.
The Company’s liquidity needs
prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to purchase Founder
Shares, and loan proceeds from the Sponsor of $300,000 under the Note (as defined in Note 4). The Company repaid the Note in full upon
closing of the Initial Public Offering. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has
been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of
the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members
of the Company’s founding team or any of their affiliates may provide the Company with Working Capital Loans (as defined in Note
4) as may be required (of which up to $1.5 million may be converted at the lender’s option into warrants).
On October 30, 2023, the Sponsor loaned
the Company $380,000 and the Company issued an unsecured promissory note in the total principal amount of up to $380,000 to the Sponsor.
On March 1, 2024, the Company issued an unsecured
convertible promissory note in the total principal amount of up to nine hundred thousand dollars $900,000 (the “Sponsor Note”)
to Sponsor. The Sponsor Note does not bear interest on the unpaid principal balance and matures upon closing of the Company’s initial
business combination. In the event that the Company does not consummate an initial business combination, the Sponsor Note will be repaid
solely to the extent that the Company has funds available to it, if any, outside of its trust account established in connection with its
initial public offering of its securities. The proceeds of the Sponsor Note will be used to fund ongoing operating expenses of the Company.
The total principal amount of the Sponsor Note may be converted, in whole or in part, at the option of the Sponsor, (i) into warrants
of the Company at a price of $1.00 per warrant, with each warrant exercisable for one Class A ordinary share, par value $0.0001 per share,
of the Company (“Class A Ordinary Share”), or (ii) into Class A Ordinary Shares equal to the quotient obtained by dividing
(i) the amount of accrued and outstanding of the promissory note, by (ii) $10.00. The warrants will be identical to the private placement
warrants issued to the Sponsor at the time of the initial public offering of the Company. As of March 31, 2024, the Company has $900,000
in borrowings under the Sponsor Note.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
In
connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40,
“Presentation of Financial Statements—Going Concern,” the Company has until September 30, 2024 (or March 31,
2025 as may be approved in accordance with an amended and restated memorandum and articles of association), to consummate a Business
Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time, and if a Business
Combination is not consummated by this date, then there will be a mandatory liquidation and subsequent dissolution of the
Company.
Management has determined that the
liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial
doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial
statements are issued. Management plans to address this uncertainty through the initial Business Combination as discussed above. There
is no assurance that the Company’s plans to consummate the initial Business Combination will be successful or successful within
the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Risks and Uncertainties
United States and global markets are
experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the
recent escalation of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization
(“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union
and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities,
including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment
system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance
to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The Russia-Ukraine conflict and the escalation of
the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States,
the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that
could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable,
they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply
chain interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the
global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Note 2—Summary of Significant
Accounting Policies
Basis of Presentation
The accompanying unaudited condensed
financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States
of America (“GAAP”) and Article 8 of Regulation S-X. Accordingly, certain disclosures included in the annual financial
statements have been condensed or omitted from these unaudited condensed financial statements as they are not required for interim financial
statements under GAAP and the rules of the SEC. In the opinion of management, all adjustments (consisting of normal accruals) considered
for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative
of the results that may be expected for the year ending December 31, 2024 or any future period.
The accompanying unaudited condensed
financial statements should be read in conjunction with the Company’s Form 10-K as filed with the SEC on March 29, 2024,
which contains the audited financial statements and notes thereto.
Emerging Growth Company
The Company is an “emerging growth
company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012
(the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the
independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
approved.
Further, Section 102(b)(1) of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that
apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such
extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt
the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public
company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Use of Estimates
The preparation of the unaudited condensed financial
statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial
statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.
Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change
in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially
subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed
the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a
significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents
The Company considers all short-term
investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash
equivalents as of March 31, 2024 and December 31, 2023.
Investments Held in the Trust
Account
The Company’s portfolio of investments
is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with
a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally
have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised
of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the
Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in
money market funds are presented on the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and
losses resulting from the change in fair value of these securities are included in income from investments held in Trust Account in the
accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined
using available market information. As of March 31, 2024 and December 31, 2023, the assets held in the Trust Account were in money market
funds.
Fair Value of Financial Instruments
The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates
the carrying amounts represented in the unaudited condensed balance sheets.
Fair Value Measurements
Fair value is defined as the price
that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants
at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair
value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level
1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
| ● | Level 1,
defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| ● | Level 2,
defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices
for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
| ● | Level 3,
defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
In some circumstances, the inputs used
to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement
is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments
The Company evaluates its financial
instruments, including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that
qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”).
For freestanding derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized
at fair value with subsequent changes in fair value recognized in the unaudited condensed statements of operations each reporting period.
The classification of freestanding derivative instruments, including whether such instruments should be classified as liabilities or as
equity, is evaluated at the end of each reporting period.
The Company evaluates embedded conversion
features within convertible debt instruments to determine whether the embedded conversion and other features should be bifurcated from
the debt host instrument and accounted for as a derivative in accordance with ASC 815.
The Company accounted for the warrants
issued in the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in ASC 815. Application
of such guidance provides that the warrants are not precluded from equity classification. The warrants were initially measured at fair
value. Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.
The Partial Over-allotment option was
recognized as a derivative liability in accordance with ASC 815. Accordingly, the Company recognized the instrument as a liability at
fair value and adjusted the instrument to fair value at each reporting period. On August 9, 2022, following the expiration of the
remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares and the derivative liability was extinguished.
The Non-Redemption Agreements was recognized
as a derivative instrument in accordance with ASC 815. The Non-Redemption Agreements represent a right to receive shares in the future
contingent upon the consummation of a business combination. Accordingly, any issuance of equity or the right to issue equity will be recorded
as an equity transaction and classified as additional paid-in capital and an expense to the company in connection to the non-redeemed
shares. The right to receive shares should be fair valued at inception and expensed in the period the agreement was entered into. As a
result of the equity classification conclusion will not be remeasured to fair valued at each reporting period.
Offering Costs Associated with
the Initial Public Offering
Offering costs consisted of legal,
accounting, underwriting and advisory fees and other costs incurred through the balance sheet date that are directly related to the Initial
Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments
issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated
to the warrants were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying
value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Class A Ordinary Shares
Subject to Possible Redemption
The Company accounts for its Class A
ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory
redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary
shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity.
At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary
shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence
of uncertain future events. Accordingly, as of March 31, 2024 and December 31, 2023, 10,056,597 and 10,056,597, respectively, Class A
ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of
the Company’s unaudited condensed balance sheets.
The Company recognizes changes in redemption
value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal
the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the
redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from
initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated
deficit.
As of March 31, 2024 and December 31,
2023, the amount of Class A ordinary shares subject to possible redemption reflected on the unaudited condensed balance sheets is
reconciled in the following table:
Gross proceeds | |
$ | 209,600,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
| (3,144,000 | ) |
Proceeds allocated to over-allotment option | |
| (20,794 | ) |
Class A ordinary shares issuance costs | |
| (12,369,649 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 23,480,261 | |
Class A ordinary shares subject to possible redemption, December 31, 2022 | |
| 217,545,818 | |
Less: | |
| | |
Redemptions | |
| (118,642,864 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 10,570,325 | |
Class A ordinary shares subject to possible redemption, December 31, 2023 | |
$ | 109,473,279 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 1,427,435 | |
Class A ordinary shares subject to possible redemption, March 31, 2024 (unaudited) | |
$ | 110,900,714 | |
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Net Income (Loss) per Ordinary Share
The Company complies with accounting
and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are
referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes
of shares.
Net income per ordinary share is computed
by dividing net income by the weighted-average number of ordinary shares outstanding during the periods. Remeasurement associated with
the redeemable Class A ordinary shares is excluded from net income per ordinary share as the redemption value approximates fair value.
Therefore, the net income per ordinary share calculation allocates income shared pro rata between Class A and Class B ordinary
shares. The Company has not considered the effect of the exercise of the Public Warrants and Private Placement Warrants to purchase an
aggregate of 17,272,000 shares in the calculation of diluted income per ordinary share, since the exercise of the warrants is
contingent upon the occurrence of future events.
The following table reflects the calculation
of basic and diluted net income per ordinary share (in dollars, except per share amounts):
| |
For the Three Months Ended March 31, | |
| |
2024 | | |
2023 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net
income (loss) per ordinary share: | |
| | | |
| | | |
| | | |
| | |
Numerator: | |
| | | |
| | | |
| | | |
| | |
Allocation of net income (loss) | |
$ | (80,616 | ) | |
$ | (42,005 | ) | |
$ | 1,606,927 | | |
$ | 401,732 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted average ordinary shares outstanding—basic and diluted | |
| 10,056,597 | | |
| 5,240,000 | | |
| 20,960,000 | | |
| 5,240,000 | |
Net income (loss) per ordinary share—basic and diluted | |
$ | (0.01 | ) | |
$ | (0.01 | ) | |
$ | 0.08 | | |
$ | 0.08 | |
Stock Compensation
The Company accounts for stock-based
compensation expense in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”).
Under ASC 718, stock-based compensation associated with equity awards is measured at fair value upon the grant date and recognized over
the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded
in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized
once the event is deemed probable to occur. Forfeitures are recognized as incurred.
Income Taxes
Income Taxes FASB ASC Topic 740, “Income
Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2024 and December
31, 2023. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2024 and December
31, 2023, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties.
The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently
no taxation imposed on income by the government of the Cayman Islands. In accordance with the Cayman Islands’ income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial
statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over
the next twelve months.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Recent Accounting Pronouncements
Management does not believe that any
recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s
unaudited condensed financial statements.
Note 3—Initial Public Offering
On June 28, 2022, the Company
consummated its Initial Public Offering of 20,000,000 Units, at $10.00 per Unit, generating gross proceeds of $200.0 million,
and incurring offering costs of approximately $12.0 million, of which $7.0 million was for deferred underwriting commissions.
The underwriter was granted the
Over-Allotment Option to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On July 20,
2022, pursuant to the underwriter’s notice of the partial exercise of the Over-Allotment Option, the Company sold an additional
960,000 Units, at $10.00 per Unit, generating aggregate additional gross proceeds of $9.6 million to the Company and incurring deferred
underwriting commissions of $336,000. The remaining Over-Allotment Option expired on August 7, 2022. On August 9, 2022,
following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares (as defined in Note
4).
Each Unit consists of one share
of Class A ordinary shares, and one-half of one redeemable warrant (each, a “Public Warrant”).
Each Public Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share,
subject to adjustment (see Note 6).
Note 4—Related Party Transactions
Founder Shares
On December 9, 2021, the sponsor
purchased 8,625,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), to cover certain
expenses on the Company’s behalf for an aggregate purchase price of $25,000. On February 24, 2022, 1,437,500 Class B
ordinary shares were surrendered and thereupon cancelled by the Company. On May 5, 2022, 1,437,500 Class B ordinary
shares were surrendered and thereupon cancelled by the Company resulting in a decrease in the total number of Class B ordinary shares
outstanding to 5,750,000 shares. The Sponsor agreed to forfeit up to an aggregate of 750,000 Founder Shares to the
extent that the option to purchase additional Units is not exercised in full by the underwriter or is reduced, so that the Founder Shares
would represent 20% of the Company’s issued and outstanding shares upon the Initial Public Offering. On July 20, 2022,
the Company sold an additional 960,000 Units in the Partial Over-Allotment Exercise pursuant to the underwriter’s notice
of the partial exercise of the Over-Allotment Option. On August 9, 2022, following the expiration of the remaining Over-Allotment
Option, the Sponsor forfeited 510,000 Founder Shares.
The initial shareholders, and the executive
officers and directors of the Company, agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (i) one
year after the completion of the initial Business Combination; and (ii) subsequent to the initial Business Combination (x) the
date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders
having the right to exchange their Class A ordinary shares for cash, securities or other property or (y) if the closing price
of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after the initial Business Combination. Any permitted transferees will be subject to the same restrictions and other agreements of the
initial shareholders with respect to any Founder Shares.
In February and March 2022, the Sponsor
transferred an aggregate of 90,000 Class B ordinary shares to the Company’s independent director nominees. The sale
of the Founder Shares is in the scope of ASC 718. The Founders Shares were granted subject to a performance condition (i.e., the
occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition
is probable of occurrence under the applicable accounting literature in this circumstance. As of March 31, 2024, the Company determined
that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based
compensation will be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination)
in an amount equal to the number of Founders Shares that ultimately vest multiplied times the grant date fair value per share (unless
subsequently modified) less the amount initially received for the purchase of the Founders Shares.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Private Placement Warrants
Simultaneously with the closing of
the Initial Public Offering, the Company consummated the Private Placement of 6,600,000 Private Placement Warrants, at a price
of $1.00 per Private Placement Warrant, in a private placement to the Sponsor, generating proceeds of $6.6 million.
Substantially concurrently with the
closing of the Partial Over-Allotment Exercise, the Company completed the Additional Private Placement of 192,000 additional
Private Placement Warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds
to the Company of $192,000.
A portion of the proceeds from the
sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company
does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The purchasers
of the Private Placement Warrants agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement
Warrants (except to permitted transferees) until 30 days after the completion of the initial Business Combination.
Related Party Loans
Promissory Note to Sponsor
The Sponsor agreed to loan the Company
up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note, dated on
December 9, 2021 and was later amended on May 5, 2022 (the “Note”). The Note was non-interest bearing, unsecured
and due upon the closing of the Initial Public Offering. The Company borrowed $300,000 under the Note and repaid the Note in full
upon closing of the Initial Public Offering. The Note was no longer available to draw on after the consummation of the Initial Public
Offering.
Overfunding Loans
On June 28, 2022, in connection with the
closing of the Initial Public Offering, the Sponsor loaned the Company $5.0 million under a non-interest bearing loan agreement
(the “First Overfunding Loan”) to deposit in the Trust Account. On July 20, 2022, in connection with the Partial Over-Allotment
Exercise, the Sponsor provided the Company with the second Overfunding Loan in the amount of $240,000 to deposit in the Trust
Account under the same terms (the “Second Overfunding Loan”, together, the “Overfunding Loans”). The Overfunding
Loans will be repaid upon the closing of an initial Business Combination or converted into Class A ordinary shares at a conversion
price of $10.00 per Class A ordinary share (or a combination of both), at the Sponsor’s discretion, provided that any
such conversion may not occur until August 22, 2022. If the Company does not complete an initial Business Combination, it will not
repay the Overfunding Loans from amounts held in the Trust Account, and the Trust Account proceeds will be distributed to the Public Shareholders;
however, the Company may repay the Overfunding Loans if there are funds available outside the Trust Account to do so. As of March 31,
2024 and December 31, 2023, the Company had $5,240,000 in borrowings under the First Overfunding Loan.
Working Capital Loans
In addition, in order to finance transaction
costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company
completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released
to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that
a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital
Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital
Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would
be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been
determined and no written agreements exist with respect to such loans. As of March 31, 2024 and December 31, 2023, the Company had no borrowings
under the Working Capital Loans.
Promissory Notes
On October 30, 2023, the Sponsor loaned the Company $380,000
and the Company issued an unsecured promissory note in the total principal amount of up to $380,000 to the Sponsor, which does not bear
interest on the unpaid principal balance and matures upon closing of the company’s initial business combination and shall be convertible
at the election of the sponsor into warrants exercisable for one Class A ordinary share of the post-business combination company at a
price of $1.00 per warrant.
On March 1, 2024, the Company issued an unsecured convertible
promissory note in the total principal amount of up to nine hundred thousand dollars ($900,000) (the “Sponsor Note”) to Sponsor.
The Sponsor Note does not bear interest on the unpaid principal balance and matures upon closing of the Company’s initial business
combination. In the event that the Company does not consummate an initial business combination, the Sponsor Note will be repaid solely
to the extent that the Company has funds available to it, if any, outside of its trust account established in connection with its initial
public offering of its securities. The proceeds of the Sponsor Note will be used to fund ongoing operating expenses of the Company. The
total principal amount of the Sponsor Note may be converted, in whole or in part, at the option of the Sponsor, (i) into warrants of the
Company at a price of $1.00 per warrant, with each warrant exercisable for one Class A ordinary share, par value $0.0001 per share, of
the Company (“Class A Ordinary Share”), or (ii) into Class A Ordinary Shares equal to the quotient obtained by dividing (i)
the amount of accrued and outstanding of the promissory note, by (ii) $10.00. The warrants will be identical to the private placement
warrants issued to the Sponsor at the time of the initial public offering of the Company.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
The promissory notes do not bear interest on the
unpaid principal balance and matures upon closing of the Company’s initial business combination. In the event that the Company does
not consummate an initial business combination, the promissory note will be repaid solely to the extent that the Company has funds available
to it, if any, outside of its trust account established in connection with its initial public offering of its securities. The proceeds
of the promissory note will be used to fund ongoing operating expenses of the Company. The total principal amount of the promissory note
may be converted, in whole or in part, at the option of the Sponsor into warrants of the post-business combination company at a price
of $1.00 per warrant, with each warrant exercisable for one Class A ordinary share, par value $0.0001 per share, of the post-business
combination company. The warrants will be identical to the private placement warrants issued to the Sponsor at the time of the initial
public offering of the Company. As of March 31, 2024 and December 31, 2023, the Company had $1,280,000 and $380,000, respectively,
in borrowings under the Promissory Notes.
Extension Loans
In order to extend the time available
for the Company to consummate its initial Business Combination by an additional three months each time, the Sponsor or its affiliates
or designees may provide an Extension Loan to the Company to provide funds to deposit into the Trust Account an additional amount of $0.10 per
share each time. The Extension Loan will be provided under the form of a non-interest bearing, unsecured promissory
note.
Such Extension Loans may be converted
into warrants upon the consummation of the initial business combination, at a price of $1.00 per warrant at the option of the lender.
The warrants would be identical to the Private Placement Warrants. If the Company completes the initial Business Combination, and the
lender decides not to convert the Extension Loans into warrants, the Company would repay such loaned amounts out of the proceeds of the
Trust Account released to the Company. If the Company does not complete a Business Combination, it will not repay such loans. The Sponsor
and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial
Business Combination. Except for the foregoing, the terms of such Extension Loans, if any, have not been determined and no written agreements
exist with respect to such loans. As of March 31, 2024 and December 31, 2023, the Company had no borrowings under the Extension Loans.
Administrative Services Agreement
On June 23, 2022, the Company
entered into an agreement with an affiliate of the Sponsor, pursuant to which the Company agreed to pay such affiliate a total of $10,000 per
month for secretarial and administrative support services provided to the Company through the earlier of consummation of the initial Business
Combination and the Company’s liquidation. The Company incurred $30,000 in such fees included as general and administrative
expenses on the accompanying unaudited condensed statements of operations for the three months ended March 31, 2024. As of March 31, 2024,
the Company fully paid for such services. The Company incurred $30,000 in such fees included as general and administrative expenses
on the accompanying unaudited condensed statements of operations for the three months ended March 31, 2023. As of March 31, 2023, the
Company fully paid for such services.
In addition, the Sponsor, officers
and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities
on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations.
The audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates
and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement
of out-of-pocket expenses incurred by such persons in connection with activities on the Company’s behalf.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Note 5—Commitments and Contingencies
Shareholder and Registration
Rights
Pursuant to a registration and shareholder
rights agreement entered into on June 23, 2022, the holders of Founder Shares, Private Placement Warrants, Class A ordinary
shares underlying the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and Extension
Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued
upon conversion of Working Capital Loans and Extension Loans), have registration rights to require the Company to register a sale of any
of the securities held by them. These holders are entitled to certain demand and “piggyback” registration rights. However,
the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.
Underwriting and Advisory Agreement
The underwriter was entitled to an
underwriting discount of $0.20 per Unit, or $4.0 million in the aggregate, paid upon the closing of the Initial Public Offering.
An additional fee of $0.35 per Unit, or approximately $7.0 million in the aggregate will be payable to the underwriter for deferred
underwriting commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in
the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
The Company also engaged Cohen &
Company Capital Markets (“CCM”) to provide consulting and advisory services to the Company in connection with the Initial
Public Offering, for which it would receive (i) an advisory fee of $400,000, paid upon the closing of the Initial Public Offering,
and (ii) a deferred advisory fee of $700,000 (payable solely in the event that the Company completes the initial Business Combination.
The underwriter has reimbursed a portion of its fees to cover for the fees payable to CCM.
In connection with the
consummation of the Partial Over-Allotment Exercise, the underwriter and CCM were entitled to an additional fee in the aggregate amount
of $192,000, paid upfront on July 20, 2022, and $336,000 in deferred underwriting and advisory commissions (net of
the reimbursement from the underwriter to cover for the fees payable to CCM).
On February 27, 2024, Deutsche Bank
Securities Inc., agreed to waive its entitlement to the payment of any underwriting discount due to it pursuant to the Underwiring Agreement
in connection with the Company’s potential business combination with Webull.
Non-Redemption Agreements
In connection with the Extension Meeting
to approve the Extension Amendment Proposal, the Company and Sponsor entered into non-redemption agreements (the “Non-Redemption
Agreements”) with several unaffiliated third parties (the “Investors”), pursuant to which such third parties agreed
not to redeem (or to validly rescind any redemption requests on) an aggregate of 8,530,242 Class A ordinary shares, par value $0.0001
per share (the “Class A Ordinary Shares”) of the Company in connection with the Extension Amendment Proposal. In exchange
for the foregoing commitments not to redeem such Class A Ordinary Shares of the Company, (i) the Sponsor agreed to surrender
to the Company and forfeit for no consideration an aggregate of 1,279,536 Class B ordinary shares, par value $0.0001 per share (the
“Class B Ordinary Shares” and together with the Class A Ordinary Shares, the “Ordinary Shares”) of the
Company and (ii) the Company agreed to issue or cause to be issued to Investors for no additional consideration an aggregate of 1,279,536
Class A Ordinary Shares of the Company, each in connection with the Company’s completion of its initial business combination.
The Non-Redemption Agreements increased the amount of funds that remain in the Company’s Trust Account following the Extension Meeting.
The Company estimated the aggregate
fair value of the Class A Ordinary Shares attributable to the Investors to be $274,826 or $0.21 per share. Accordingly, in substance,
it was recognized by the Company as an expense to induce these holders of the Class A shares not to redeem, with a corresponding
charge to additional paid-in capital to recognize the fair value of the shares transferred as an offering cost.
The fair value of the Class A Ordinary
Shares was based on a Monte Carlo model using the following significant inputs:
| |
December 27,
2023 | |
Stock price | |
$ | 10.86 | |
Volatility | |
| 40.00 | % |
Term (years) | |
| 1.59 | |
Risk-free rate | |
| 4.44 | % |
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Business Combination Agreement
On February 27, 2024, the Company
(“SPAC”), Webull Corporation, an exempted company limited by shares incorporated under the laws of the Cayman Islands (“Webull”),
Feather Sound I Inc., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned
subsidiary of Webull (“Merger Sub I”),and Feather Sound II Inc., an exempted company limited by shares incorporated under
the laws of the Cayman Islands and a direct wholly owned subsidiary of Webull (“Merger Sub II”, collectively with Merger Sub
I, the “Merger Subs” and each a “Merger Sub”),entered into a business combination agreement (the “Business
Combination Agreement”).
Subject to, and in accordance with the terms and conditions
of the Business Combination Agreement, (i) immediately prior to the effective time of the First Merger (as defined below) (the “First
Merger Effective Time”), Webull will effectuate the Company Capital Restructuring (as defined in the Business Combination Agreement),
(ii) promptly following the Webull Capital Restructuring and at the First Merger Effective Time, Merger Sub I will merge with and into
us (the “First Merger”), with us surviving the First Merger as a wholly owned subsidiary of Webull (sometimes referred to
herein as the “Surviving Entity”), and (iii) promptly following the First Merger and at the effective time of the Second Merger
(as defined below) (the “Second Merger Effective Time”), the Surviving Entity will merge with and into Merger Sub II (the
“Second Merger”, together with the First Merger, the “Mergers”), with Merger Sub II surviving the Second Merger
as a wholly owned subsidiary of Webull. The Webull Capital Restructuring, the Mergers and each of the other transactions contemplated
by the Business Combination Agreement or other transaction documents are collectively referred to as the “Transactions” or
the “Business Combination”.
Concurrently with the execution and
delivery of the Business Combination Agreement, SPAC, Webull and Sponsor and certain directors (collectively, “SPAC Insiders”)
have entered into a support agreement (the “Sponsor Support Agreement”), pursuant to which, each SPAC Insider agreed, among
other things, (a) at any meeting of SPAC shareholders called to seek the SPAC Shareholders’ Approval or SPAC Shareholder Extension
Approval (as defined in the Business Combination Agreement), or in connection with any written consent of SPAC shareholders or in any
other circumstances upon which a vote, consent or other approval with respect to the Business Combination Agreement and the Transactions,
such SPAC Insider (i) agreed to, if a meeting is held, appear at such meeting or otherwise cause the SPAC Class B Ordinary Shares
held by such SPAC Insider to be counted as present at such meeting for purposes of establishing a quorum, and (ii) vote or cause
to be voted the SPAC Class B Ordinary Shares held by such SPAC Insider in favor of the SPAC Shareholders’ Approval or the SPAC
Shareholder Extension Approval; and (b) subject to the exceptions set forth in the Sponsor Support Agreement, agreed to become subject
to certain transfer restrictions with respect to (i) any Company Ordinary Shares held by each SPAC Insider immediately after the
First Merger Effective Time (as defined in the Business Combination Agreement) during a period of twelve (12) months from and after
the Closing Date (as defined in the Business Combination Agreement), (ii) Company Warrants or Class A Ordinary Shares underlying
such warrants held by each SPAC Insiders immediately after the First Merger Effective Time until thirty (30) days after the Closing
Date.
Sponsor
also agreed to forfeit for no consideration up to 2,000,000 SPAC Class B Ordinary Shares held by Sponsor in connection with the execution
of additional Non-Redemption Agreements following the date of the Business Combination Agreement. In addition, on the terms and subject
to the conditions of the Sponsor Support Agreement, Webull agreed to indemnify Sponsor and each other SPAC Insider for any U.S. federal
(and applicable U.S. state and U.S. local) income taxes, together with any interests and penalties (the “Indemnifiable Amounts”)
payable by Sponsor or the SPAC Insiders, as applicable, solely arising from or attributable to the failure of the Mergers (as defined
in the Business Combination Agreement) to qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue
Code of 1986, as amended (the “Code”) or as an exchange described in Section 351 of the Code (the “Intended
Tax Treatment”), provided, however, that the Company shall not have any liability in respect of any Indemnifiable Amounts to the
extent that the aggregate amount of such Indemnifiable Amounts exceeds $5,000,000.
Note 6—Class A Ordinary Shares Subject to
Possible Redemption and Shareholders’ Deficit
Preference
Shares—The Company is authorized to issue 990,000 preference shares, par value $0.0001 per share.
As of March 31, 2024 and December 31, 2023, there were no preference shares issued or outstanding.
Class A
Ordinary Shares—The Company is authorized to issue 9,000,000,000 Class A ordinary shares with a par
value of $0.0001 per share. As of March 31, 2024 and December 31, 2023, there were 10,056,597, respectively, Class A ordinary
shares issued and outstanding, all of which were subject to possible redemption and were classified outside of permanent equity on the
unaudited condensed balance sheets.
Class B
Ordinary Shares—The Company is authorized to issue 999,000,000 Class B ordinary shares with a par
value of $0.0001 per share. As of December 31, 2022, there were 5,240,000 Class B ordinary shares issued and outstanding,
which amounts have been retroactively restated to reflect the share surrenders of Class B ordinary shares to the Company on February 24,
2022 and May 5, 2022 as discussed in Note 4. Of the 5,750,000 Class B ordinary shares outstanding, up to an aggregate of 750,000
shares was subject to forfeiture to the extent that the option to purchase additional Units is not exercised in full by the underwriter
or is reduced, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public
Offering. On July 20, 2022, the Company sold an additional 960,000 Units in the Partial Over-Allotment Exercise pursuant to the underwriter’s
notice of the partial exercise of the Over-Allotment Option. On August 9, 2022, following the expiration of the remaining Over-Allotment
Option, the Sponsor forfeited 510,000 Founder Shares. As of March 31, 2024 and December 31, 2023 there were 5,240,000 Class B ordinary
shares issued and outstanding.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
Ordinary shareholders of record are
entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of
the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted
to a vote of the Company’s shareholders, except as required by law.
The Class B ordinary shares will
automatically convert into Class A ordinary shares at the time of the initial Business Combination or earlier at the option of the
holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal,
in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued
and outstanding upon completion of the Initial Public Offering, plus (ii) (a) the total number of Class A ordinary shares issued
or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company
in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares
or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued to
any seller in the initial Business Combination and any private placement warrants issued to the Sponsor, its affiliates or any member
of the management team upon conversion of Working Capital Loans and Extension Loans and (b) any Class A ordinary shares
issued to the Sponsor upon conversion of Overfunding Loans. Any conversion of Class B ordinary shares described herein will take
effect as a compulsory redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman
Islands law. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one
to one.
Warrants—As
of March 31, 2024 and December 31, 2023, the Company had 10,480,000 Public Warrants and 6,792,000 Private Placement
Warrants outstanding. Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation
of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion
of a Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the shares
of ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company
permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the
Securities Act). The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing
of the Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration,
under the Securities Act, of the ordinary shares issuable upon exercise of the Public Warrants and the Private Placement Warrants. The
Company will use its best efforts to cause the same to become effective within 60 business days after the closing of the Business
Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration
of the Public Warrants and the Private Placement Warrants in accordance with the provisions of the warrant agreement. Notwithstanding
the foregoing, if the Company’s ordinary shares are at the time of any exercise of a warrant not listed on a national securities
exchange such that it satisfies the definition of a “covered security” under the Securities Act, the Company, at its option,
may require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9)
of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration
statement. The Public Warrants and Private Placement Warrants will expire five years after the completion of the Business Combination
or earlier upon the Company’s redemption or liquidation.
The warrants have an exercise price
of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith
by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account
any Founder Shares held by such shareholder) (the “Newly Issued Price”), (y) the proceeds from such issuances represent more
than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the
date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price
of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the
Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise
price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly
Issued Price, and the $18.00 per share redemption trigger price described under “Redemption of Public Warrants” will
be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2024
The Private Placement Warrants are
identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants
(i) will not be redeemable by the Company, (ii) may not, subject to certain limited exceptions, be transferred, assigned or
sold by the holders (and the Class A ordinary shares issuable upon exercise of these warrants may not be transferred, assigned or
sold by the holders) until 30 days after the completion of the initial Business Combination, (iii) may be exercised by
the holders on a cashless basis and (iv) will be entitled to registration rights.
Redemption
of Public Warrants: Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants:
| ● | in whole and not in part; |
| | |
| ● | at a price of $0.01 per warrant; |
| | |
| ● | upon a minimum of 30 days’ prior written notice of redemption, the “30-day redemption period”; and |
| | |
| ● | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant. |
The Company will not redeem the Public
Warrants as described above unless (an effective registration statement under the Securities Act covering the Class A ordinary shares
issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available
throughout the 30-day redemption period or the Company has elected to require the exercise of the Public Warrants
on a “cashless basis”. If the Company calls the Public Warrants for redemption as described above, the Company will have the
option to require all holders that wish to exercise such warrants to do so on a “cashless basis.”
Note 7—Fair Value Measurements
The following tables present information
about the Company’s financial assets that are measured at fair value on a recurring basis as March 31, 2024 and December 31, 2023
by level within the fair value hierarchy:
March 31, 2024 | |
Description | | |
Quoted
Prices in
Active
Markets
(Level 1) | | |
Significant
Other
Observable
Inputs
(Level 2) | | |
Significant Other
Unobservable
Inputs
(Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Investments held in Trust Account – Money Market Funds | |
| | | |
$ | 111,000,714 | | |
$ | — | | |
$ | — | |
December 31, 2023 | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| |
Investments held in Trust Account – Money Market Funds | |
$ | 109,573,279 | | |
$ | — | | |
$ | — | |
Transfers to/from Levels 1, 2, and
3 are recognized at the beginning of the reporting period. There were no transfers between levels during the period ended March 31, 2024
and December 31, 2023.
Note 8—Subsequent Events
The Company evaluated subsequent events
and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued.
Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in
the unaudited condensed financial statements.
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report (the “Quarterly
Report”) to “we,” “us” or the “Company” refer to SK Growth Opportunities Corporation References
to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor”
refer to Auxo Capital Managers LLC. The following discussion and analysis of the Company’s financial condition and results of operations
should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly
Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve
risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially
from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including,
without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations”
regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,”
“estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially from
the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could
cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section
of the Company’s Annual Report on Form 10-K filed with the SEC on March 29, 2024. The Company’s securities filings can be
accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the
Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information,
future events or otherwise.
Overview
We are a blank check company incorporated in the
Cayman Islands on December 8, 2021. The Company was formed for the purpose of effecting a
merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our Sponsor is Auxo Capital Managers LLC, a Delaware
limited liability company. The registration statement for our Initial Public Offering was declared effective on June 23, 2022. On June
28, 2022, we consummated our Initial Public Offering of 20,000,000 Units, at $10.00 per Unit, generating gross proceeds of $200.0 million,
and incurring offering costs of approximately $12.0 million, of which $7.0 million was for deferred underwriting commissions. The underwriter
was granted a 45-day option from the date of the final prospectus relating to the Initial
Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On July 20, 2022, pursuant
to the underwriter’s notice of the partial exercise of the Over-Allotment Option, we sold an additional 960,000 Units, at $10.00
per Unit, generating aggregate additional gross proceeds of $9.6 million to us. On August 7, 2022, the remaining Over-Allotment Option
expired unexercised.
On August 10, 2022, the Company announced that,
effective August 15, 2022, the Company’s Class A ordinary shares and warrants comprising each issued and outstanding Unit will commence
trading separately under the ticker symbols “SKGR” and “SKGW,” respectively. Holders of Units may elect to continue
to hold Units or separate their Units into the component securities.
Simultaneously with the closing of the Initial
Public Offering, we consummated the Private Placement of 6,600,000 Private Placement Warrants, at a price of $1.00 per Private Placement
Warrant in a private placement to our Sponsor, generating proceeds of $6.6 million. Substantially concurrently with the closing of the
Partial Over-Allotment Exercise, we completed an additional private placement of 192,000 Private Placement Warrants to our Sponsor at
a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $192,000.
In addition, upon the consummation of the Initial
Public Offering on June 28, 2022, our Sponsor provided us with the First Overfunding Loan in the amount of $5.0 million to deposit in
the Trust Account at no interest. In connection with the Partial Over-Allotment Exercise on July 20, 2022, our Sponsor provided us with
the Second Overfunding Loan in the amount of $240,000 to deposit in the Trust Account.
Upon the closing of the Initial Public Offering
and the Partial Over-Allotment Exercise, approximately $214.8 million ($10.25 per Unit) of net proceeds, including the net proceeds of
the Initial Public Offering, the Partial Over-Allotment Exercise, the proceeds of the Overfunding Loans and certain of the proceeds of
the Private Placement and the Additional Private Placement, was placed in the Trust Account located in the United States with Continental
Stock Transfer & Trust Company acting as trustee, and invested only in United States
“government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days
or less or in money market funds meeting certain conditions under Rule2a-7promulgated under the Investment Company Act which invest only
in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination
and (ii) the distribution of the Trust Account as described below.
We will provide the Public Shareholders with the
opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with
a shareholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether we will
seek shareholder approval of a Business Combination or conduct a tender offer will be made by us, solely in its discretion. The Public
Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially
at $10.25 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be
reduced by the deferred underwriting commissions we will pay to the underwriter.
If we cannot consummate the initial business combination
by September 1, 2024 and it is reasonably determined by us and Webull that we may not be able to consummate the initial business combination
by September 30, 2024, we will (a) use our reasonable best efforts to cause the our board of directors to approve such amendment to our
memorandum and articles of association, as amended, to provide that the date by which we must consummate a business combination in accordance
with our memorandum and articles of association, as amended, is extended from September 30, 2024 to March 31, 2025 (such period by which
we must consummate a business combination, as amended, and as may be extended in accordance with the provisions of the Business Combination
Agreement, the “Combination Period” and such proposal, the “Extension Proposal”) and resolve to recommend that
the our shareholders approve such Extension Proposal by special resolution, which is a resolution passed by a majority of at least two-thirds
of such members of the company as, being entitled to do so, vote in person or by proxy at a general meeting, and includes a unanimous
written resolution (the “Extension Recommendation”), and not change or modify or propose to change or modify the Extension
Recommendation, and (b) prepare and file with the SEC proxy statement (such proxy statement, together with any amendments or supplements
thereto, the “Extension Proxy Statement”) for the purpose of soliciting proxies from our shareholders for the Extension Proposal,
which shall include, among other things, (x) a description and introduction of Webull, and (y) a statement that the Business Combination
Agreement and any other transaction documents have been entered into. We shall discuss in good faith with Webull and agree upon the terms
of the Extension Proposal, including the proposed amendments to our memorandum and articles of association and additional economic incentives,
if any, to be offered to our shareholders in connection with their approval of the Extension Proposal.
If we are unable to consummate an initial business combination within
the Combination Period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible
but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes payable and
up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption
will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions,
if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders
and the board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims
of creditors and the requirements of other applicable law.
Proposed Business Combination
On February 27, 2024, we entered into a Business
Combination Agreement (as may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”)
with Webull Corporation, an exempted company limited by shares incorporated under the laws of the Cayman Islands (“Webull”),
Feather Sound I Inc., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned
subsidiary of Webull (“Merger Sub I”) and Feather Sound II Inc., an exempted company limited by shares incorporated under
the laws of the Cayman Islands and a direct wholly owned subsidiary of Webull (“Merger Sub II”).
Termination
The Business Combination Agreement may be terminated
under certain customary and limited circumstances prior to the First Merger Effective Time, including, among others: (i) by mutual written
consent of Webull and us; (ii) by Webull or us if any law or governmental order is in effect that has become final and non-appealable
and has the effect of making the consummation of the Transactions illegal or otherwise preventing or prohibiting consummation of the Transactions;
(ii) by Webull if our board or any of its committees shall have withheld, withdrawn, qualified, amended or modified, or publicly proposed
to do any of the foregoing, with respect to our board recommendation that our shareholders vote in favor of the SPAC Transaction Proposals
(as defined in the Business Combination Agreement) at the duly convened meeting of our shareholders, (iii) by Webull if we shall have
failed to obtain the approval of our shareholders in an extraordinary general meeting in connection with the amendment to our organizational
documents to extend the deadline for us to consummate an initial business combination; (iv) by Webull or us if the SPAC Shareholders’
Approval shall not have been obtained at the meeting of our shareholders, (v) by Webull or us if the required approval by the shareholders
of the Webull shall not have been obtained; (vi) by Webull or us upon a breach of or failure to perform any representations, warranties,
covenants or other agreements set forth in the Business Combination Agreement by the other party if such breach gives rise to a failure
of certain closing conditions to be satisfied and cannot or has not been cured; and (vii) by Webull or us if the Transactions shall not
have been consummated on or prior to the March 31, 2025, in each case subject to specified exceptions.
The Business Combination Agreement and related
agreements are further described in our Current Report on Form 8-K filed with the SEC on February 28, 2024. Other than as specifically
discussed, this Quarterly Report does not assume the closing of the Business Combination or the transactions contemplated by the Business
Combination Agreement.
Sponsor Support Agreement
Concurrently with the execution and delivery of
the Business Combination Agreement, we have entered into a support agreement with Webull and the SPAC Insiders (the “Sponsor Support
Agreement”), pursuant to which, each SPAC Insider agreed, among other things, (a) at any meeting of our shareholders called to seek
SPAC Shareholders’ Approval or SPAC Shareholder Extension Approval (as defined in the Business Combination Agreement), or in connection
with any written consent of our shareholders or in any other circumstances upon which a vote, consent or other approval with respect to
the Business Combination Agreement and the Transactions, such SPAC Insider (i) agreed to, if a meeting is held, appear at such meeting
or otherwise cause our Class B ordinary shares held by such SPAC Insider to be counted as present at such meeting for purposes of establishing
a quorum, and (ii) vote or cause to be voted our Class B ordinary shares held by such SPAC Insider in favor of the SPAC Shareholders’
Approval or the SPAC Shareholder Extension Approval; and (b) subject to the exceptions set forth in the Sponsor Support Agreement, agreed
to become subject to certain transfer restrictions with respect to (i) any Webull Ordinary Shares held by each SPAC Insider immediately
after the First Merger Effective Time during a period of twelve (12)-months from and after the Closing Date, (ii) Webull Class A ordinary
share (the “Webull Warrants”) or class A ordinary shares of Webull, par value $0.00001 per share (the “Webull Class
A Ordinary Shares”) underlying such warrants held by each SPAC Insiders immediately after the First Merger Effective Time until
thirty (30) days after the Closing Date.
Following the date of the Business Combination
Agreement, we and our sponsor will use commercially reasonable efforts to enter into additional Non-Redemption Agreements with our public
shareholders, pursuant to which our sponsor will be required to forfeit for no consideration 2,000,000 of Class B ordinary shares held
by our sponsor. To the extent the aggregate amount of our Class B ordinary shares to be forfeited by our sponsor pursuant to such additional
Non-Redemption Agreements is less than 2,000,000, our sponsor will forfeit an additional amount of our Class B ordinary shares on the
Closing Date and immediately prior to the First Merger Effective Time, such that our sponsor will forfeit an aggregate of 2,000,000 Class
B ordinary shares pursuant to such additional Non-Redemption Agreements and the Sponsor Support Agreement.
In addition, on the terms and subject to the conditions
of the Sponsor Support Agreement, following the closing of the Business Combination until 30 days following the expiration of the statute
of limitations for the applicable taxes (or if an audit is commenced during this period, until the completion of the audit), subject to
the occurrence of certain triggering events, Webull agreed to indemnify our sponsor and each other SPAC Insiders for any U.S. federal
(and applicable U.S. state and U.S. local) income taxes, together with any interests and penalties (the “Indemnifiable Amounts”)
payable by our sponsor or the other SPAC Insiders, as applicable, solely arising from or attributable to the failure of the Mergers to
qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”)
or as an exchange described in Section 351 of the Code, provided, however, that Webull shall not have any liability in respect of any
Indemnifiable Amounts to the extent that the aggregate amount of such Indemnifiable Amounts exceeds $5,000,000.
The foregoing description of the Sponsor Support
Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of the Sponsor Support Agreement,
a copy of which is filed with our Current Report on Form 8-K filed with the SEC on February 28, 2024 which is incorporated by reference
herein.
Going Concern Consideration
As of March 31, 2024, the company had $536,588
in cash and working capital deficit of approximately $2.9 million.
Our liquidity needs prior to the consummation of
the initial public offering were satisfied through the payment of $25,000 from our sponsor to purchase founder shares, and loan proceeds
from our sponsor of $300,000 under a promissory note, dated December 9, 2021 that was later amended on May 5, 2022 (the “Note”).
We repaid the Note in full upon closing of the initial public offering. Subsequent to the consummation of the initial public offering,
our liquidity has been satisfied through the net proceeds from the consummation of the initial public offering, the overfunding loans
and the private placement held outside of the trust account. In addition, in order to finance transaction costs in connection with a business
combination, our sponsor, members of our founding team or any of their affiliates may provide us with working capital loans as may be
required (of which up to $1.5 million may be converted at the lender’s option into warrants).We have incurred and expect to continue
to incur significant costs in pursuit of our acquisition plans. In connection with our assessment of going concern considerations in accordance
with FASB ASC Topic 205-40, “Presentation of Financial Statements-Going Concern,” we have until September 30, 2024 (or March
31, 2025 as may be approved as described in our Annual Report on Form 10-K filed with the SEC on March 29, 2024) to consummate a business
combination. It is uncertain that we will be able to consummate a business combination by this time, and if a business combination is
not consummated by this date, then there will be a mandatory liquidation and subsequent dissolution of our company.
Our management has determined that the liquidity
condition and mandatory liquidation, should a business combination not occur, and potential subsequent dissolution raises substantial
doubt about our ability to continue as a going concern for a period of time within one year after the date that the financial statements
are issued. Our management plans to address this uncertainty through the initial business combination as discussed above. There is no
assurance that our plans to consummate the initial business combination will be successful or successful by September 30, 2024 (or March
31, 2025 as may be approved as described in our Annual Report on Form 10-K filed with the SEC on March 29, 2024). The financial statements
do not include any adjustments that might result from the outcome of this uncertainty.
Risks and Uncertainties
United States and global markets are experiencing
volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation
of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”)
deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain
countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and
to Israel, increasing geopolitical tensions among a number of nations. The Russia-Ukraine conflict and the escalation of the Israel-Hamas
conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom,
the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting
impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could
lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain
interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global
economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russia-Ukraine conflict, the
escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search
for an initial business combination and any target business with which the Company may ultimately consummate an initial business combination.
Results of Operations
Our entire activity since inception up to March
31, 2024, related to our formation, the preparation for the Initial Public Offering, and since
the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We will not be generating any operating
revenues until the closing and completion of our initial Business Combination.
For the three months ended March 31, 2024, we had
a net loss of approximately $123,000, which consisted of approximately $1.4 million in income from investments held in the trust account,
offset by approximately $1,550,000 in general and administrative expenses (of which $30,000 was for administrative expenses for related
party).
For the three months ended March 31, 2023, we had
a net income of $2,008,659, which consisted of $2,300,710 in income from investments held in the Trust Account, offset by $292,051 in
general and administrative expenses (of which $30,000 was for administrative expenses for related party).
Contractual Obligations
Shareholder and Registration Rights
Pursuant to a registration and shareholder rights
agreement entered into on June 23, 2022, the holders of Founder Shares, Private Placement Warrants, Class A ordinary shares underlying
the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and Extension Loans (and any
Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of
Working Capital Loans and Extension Loans), have registration rights to require us to register a sale of any of the securities held by
them. These holders are entitled to certain demand and “piggy-back” registration rights. However, the registration rights
agreement provides that we will not be required to effect or permit any registration or cause any registration statement
to become effective until termination of the applicable lock-up period. We will bear the expenses incurred in connection with the filing
of any such registration statements.
Underwriting and Advisory Agreement
The underwriter was entitled
to an underwriting discount of $0.20 per Unit, or $4.0 million in the aggregate, paid upon the closing of the Initial Public Offering.
An additional fee of $0.35 per Unit, or approximately $7.0 million in the aggregate will be payable to the underwriter for deferred underwriting
commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that
we complete a Business Combination, subject to the terms of the underwriting agreement.
We also engaged Cohen & Company Capital Markets
(“CCM”) to provide consulting and advisory services to us in connection with the Initial Public Offering, for which it would
receive: (i) an advisory fee of $400,000, paid upon the closing of the Initial Public Offering, and (ii) a deferred advisory fee of $700,000
(payable solely in the event that we complete the initial Business Combination. The underwriter has reimbursed a portion of their fees
to cover for the fees payable to CCM.
In connection with the consummation of the
Partial Over-Allotment Exercise, the underwriter and CCM were entitled to an additional fee of $192,000, paid upfront on July 20, 2022,
and $240,000 in deferred underwriting and advisory commissions, (net of the reimbursement from the underwriter to cover for the fees payable
to CCM).
Administrative Services Agreement
On June 23, 2022, we entered into an agreement
with an affiliate of our sponsor, pursuant to which we agreed to pay such affiliate a total of $10,000 per month for secretarial and administrative
support services provided to us through the earlier of consummation of the initial business combination and our liquidation. We incurred
$30,000 in such fees included as general and administrative expenses on the accompanying unaudited condensed statements of operations
for the three months ended March 31, 2024. As of March 31, 2024, we fully paid for such services. We incurred $30,000 in such fees included
as general and administrative expenses on the accompanying unaudited condensed statements of operations for the three months ended March
31, 2023. As of March 31, 2023, we fully paid for such services.
In addition, our sponsor, officers and directors,
or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our
behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The audit committee
will review on a quarterly basis all payments that were made to our sponsor, officers, directors or their affiliates and will determine
which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses
incurred by such persons in connection with activities on our behalf.
Critical Accounting Estimates
The preparation of the unaudited condensed financial
statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent
assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts of income and expenses during
the periods reported. Actual results could materially differ from those estimates. We have identified the following as critical accounting
estimates.
Derivative Financial Instruments
We evaluate our financial instruments, including
equity-linked financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC
815”). For freestanding derivative financial instruments that are classified as liabilities, the derivative instrument is initially
recognized at fair value with subsequent changes in fair value recognized in the unaudited condensed statements of operations each reporting
period. The classification of freestanding derivative instruments, including whether such instruments should be classified as liabilities
or as equity, is evaluated at the end of each reporting period.
We evaluate embedded conversion features within
convertible debt instruments to determine whether the embedded conversion and other features should
be bifurcated from the debt host instrument and accounted for as a derivative in accordance with ASC 815.
We accounted for Public Warrants and the Private
Placement Warrants in accordance with the guidance contained in ASC 815. Application of such guidance provides that the warrants are not
precluded from equity classification. The warrants were initially measured at fair value. Subsequent changes in fair value are not recognized
as long as the contracts continue to be classified in equity.
The Over-Allotment Option was recognized as a derivative
liability in accordance with ASC 815. Accordingly, we recognized the instrument as a liability at fair value and adjusted the instrument
to fair value at each reporting period. On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor
forfeited 510,000 Founder Shares and the derivative liability was extinguished.
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A ordinary shares subject
to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are
classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class
A ordinary shares that feature redemption rights that are either within the control of the
holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity.
At all other times, Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain
redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly,
as of March 31, 2024, 10,056,597 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of
the shareholders’ deficit section of our unaudited condensed balance sheets.
We recognize changes in redemption value immediately
as they occur and adjust the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value
at the end of each reporting period. This method would view the end of the reporting period
as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, we recognized the
accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available)
and accumulated deficit.
Recent Accounting Pronouncements
Our management do not believe that any recently
issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited
condensed financial statements.
Off-Balance Sheet Arrangements and Contractual Obligations
As of March 31, 2024, we did not have any off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.
JOBS Act
On April 5, 2012, the JOBS Act was signed into
law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies.
We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements
based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such
standards is required for non-emerging growth companies. As a result, our unaudited condensed financial statements may not be comparable
to companies that comply with new or revised accounting pronouncements as of public company effective dates.
As an “emerging growth company”, we
are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial
reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public
companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by
the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about
the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items
such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median
employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering
or until we are no longer an “emerging growth company,” whichever is earlier.
Item
3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by
Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item
4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed
to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported
within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our
management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions,
as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation
of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness
of our disclosure controls and procedures as of March 31, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange
Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded that during the period covered
by this report, our disclosure controls and procedures were effective as of March 31, 2024.
Changes in Internal Control Over Financial Reporting
During the most recently completed fiscal quarter,
there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II-OTHER INFORMATION
ITEM
1. LEGAL PROCEEDINGS
None.
ITEM
1A. RISK FACTORS
Except as set forth below, as of the date of this
Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed
with the SEC on March 29, 2024. We may disclose changes to such factors or disclose additional factors from time to time in our future
filings with the SEC.
The underwriters of our initial public offering were to be compensated
in part on a deferred basis for already-rendered services in connection with our initial public offering. However, Deutsche Bank Securities
Inc. (“DB”) gratuitously waived such compensation with respect to the Business Combination with Webull. DB had no role in
this Business Combination and does not have any responsibility for disclosure that is or will be included in any proxy statement/prospectus
in connection with the Business Combination.
Pursuant to the underwriting
agreement we entered into in connection with our initial public offering, DB was entitled to deferred underwriting commissions in the
aggregate amount of approximately $7.0 million as consideration for services rendered to us in connection with our initial public offering,
which was to become payable upon consummation of a business combination transaction. Even though the services of DB for such deferred
underwriting commissions had already been rendered in full in connection with our initial public offering, DB gratuitously waived its
entitlement to the payment of the deferred underwriting commissions with respect to the Business Combination on February 27, 2024. Accordingly,
the underwriters of our initial public offering will not receive any portion of the deferred underwriting commissions. DB was not provided,
and will not be provided, from any source, any consideration in exchange for its waiver of its entitlement to the payment of the deferred
underwriting commissions with respect to the Business Combination. The waiver is only with respect to the deferred underwriting commission
in connection with the Business Combination, DB may be entitled to other indemnification or contribution pursuant to the underwriting
agreement entered into in connection with our initial public offering. DB did not provide a reason for gratuitously granting the waiver
and we did not engage in any substantive dialogue with DB regarding the reason for waiving the deferred underwriting commissions.
DB has not played any role in connection with the
Business Combination, and has not been involved in the preparation of any disclosure that is or will be included in any proxy statement/prospectus
in connection with the Business Combination, or any business analysis underlying such disclosure. Accordingly, DB has produced no work
product in relation to the Business Combination for which we relied on their expertise. As a result, our shareholders do not have the
benefit of DB’s independent review and investigation of the disclosures provided in any proxy statement/prospectus, and should not
place any reliance on the fact that DB was involved with our initial public offering. Investors should be aware that the waiver of a deferred
underwriting commission is unusual and some investors may find the Business Combination less attractive as a result, which may make it
more difficult for us to complete the Business Combination.
The Sponsor and our directors and officers have interests that
are different from, or in addition to (and which may conflict with), the interests of its shareholders, and therefore potential conflicts
of interest exist in recommending that shareholders vote in favor of the Business Combination. Such conflicts of interests include that
the Sponsor as well as our directors and officers are expected to lose their entire investment in the Company if the Business Combination
is not completed.
When considering our Board’s recommendation
to vote in favor of approving any proposals in connection with the Business Combination, our shareholders should keep in mind that the
Sponsor and our directors and officers have interests in such proposals that are different from, or in addition to (and which may conflict
with), those of our shareholders and warrant holders generally.
These interests include, among other things:
| ● | The fact that immediately following the consummation of the Business
Combination, the initial shareholders are expected to hold an aggregate of 2,484,464 Webull Class A Ordinary Shares on an as-converted
basis, consisting of (i) 1,960,464 Webull Class A Ordinary Shares to be exchanged from our Class B ordinary shares held
by the initial shareholders, and (ii) 524,000 Webull Class A Ordinary Shares to be converted from the Overfunding Loans; and
up to 8,072,000 Webull Class A Ordinary Shares underlying the Webull Warrants to be converted from our Private Placement Warrants
(including our Private Placement Warrants that may be converted from the Working Capital Loans) at the First Merger Effective Time, each
entitling the Sponsor to purchase one Webull Class A Ordinary Share at a price of $11.50 per share 30 days after the closing
of the Business Combination (“Closing”), which in the aggregate, would represent approximately 1.30% and 1.33% ownership interest
in Webull following the consummation of the Business Combination under the no redemption scenario and the maximum redemption scenario,
respectively, on an as converted basis. |
| ● | The fact that the Sponsor acquired 6,600,000 of our Private
Placement Warrants at a purchase price of $1.00 per warrant, and an additional 192,000 of our Private Placement Warrants at a purchase
price of $1.00 per warrant, upon an over-allotment exercise on July 20, 2022. |
|
● |
The fact that the Sponsor paid an aggregate of $25,000, or approximately $0.003 per share, for 8,625,000 Founder Shares prior to the our initial public offering, of which (i) 2,875,000 Founder Shares were surrendered and cancelled by us prior to our initial public offering, (ii) 90,000 Founder Shares were transferred to our independent directors prior to our initial public offering, (iii) 510,000 Founder Shares were forfeited due to the failure of the underwriter to fully execute their over-allotment option; (iv) 1,279,536 Founder Shares will be surrendered to us and forfeited for no consideration immediately prior to the First Merger Effective Time in connection with that certain Non-Redemption Agreements with unaffiliated third-party investors entered into in December 2023, and (v) 2,000,000 Founder Shares shall be surrendered to us and forfeited for no consideration immediately prior to the First Merger Effective Time pursuant to the Sponsor Support Agreement and the Additional Non-Redemption Agreements. All of the remaining Founder Shares are subject to certain transfer restrictions and such remaining 1,870,464 Founder Shares could have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $20.8 million, based on the most recent closing price of the our Class A ordinary shares of $11.12 per share on May 6, 2024. |
|
● |
The fact that our independent directors own an aggregate of 90,000 Founder Shares that were acquired from the Sponsor at a purchase price of approximately $0.003 per share. The 90,000 Founder Shares held by such independent directors are subject to certain transfer restrictions and such Founder Shares could have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $1.0 million, based on the most recent closing price of the our Class A ordinary shares of $11.05 per share on May 6, 2024. |
| ● | The fact that if the Business Combination or another business
combination is not consummated by September 30, 2024 (or March 31, 2025 as may be approved in accordance with an amended and restated
memorandum and articles of association), we will cease all operations except for the purpose of winding up, redeeming 100% of our outstanding
public shares for cash and, subject to the approval of its remaining shareholders and our Board, liquidating and dissolving. In such
event, the Founder Shares held by the Sponsor and our independent directors, and the 6,792,000 of our Private Placement Warrants held
by the Sponsor (for which the Sponsor paid an aggregate of approximately $6.8 million) would be worthless because the holders of our
Class B ordinary shares are not entitled to participate in any redemption or liquidating distribution with respect to these shares
and the our Private Placement Warrants will not be exercisable. If the Business Combination is not consummated, the Sponsor will forfeit
an aggregate of 3,279,536 Founder Shares pursuant to the Non-Redemption Agreements and/or the Sponsor Support Agreement, assuming the
Webull Class A Ordinary Shares to be issued to the initial shareholders are valued at $10.00, and further taking into account the Working
Capital Loans extended by the Sponsor to us and any net fees due, both of which will not be paid, the Sponsor could potentially lose
approximately $20.9 million in the aggregate. In addition, our independent directors could lose in the aggregate of $900,000 with respect
to their Founder Shares. On the other hand, if the Business Combination is consummated, each of our outstanding Ordinary Share will be
converted into one Webull Class A Ordinary Share, and each of our Warrant will be converted into one Webull Warrant. Given (i) the
differential in the purchase price that the Sponsor paid for the Founder Shares, as compared to the price of the our Class A ordinary
shares, (ii) the differential in the purchase price that the Sponsor paid for the our Private Placement Warrants as compared to
the price of the Public Warrants, and (iii) the substantial number of Webull Class A Ordinary Shares that the Sponsor and these
directors will receive upon conversion of the Founder Shares and/or our Private Placement Warrants, the Sponsor and these directors can
earn a positive return on their investment, even if Public Shareholders have a negative return on their investment. |
| ● | The fact that if the Trust Account is liquidated, the Sponsor
has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below the lesser of (i) $10.25 per Public
Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account
if less than $10.25 per Public Share due to reductions in the value of the trust assets, in each case net of the interest that may be
withdrawn to pay our tax obligations, by the claims of (1) any third party for services rendered or products sold to us or (2) a
prospective target business with which we have entered into a letter of intent, confidentiality or other similar agreement or business
combination agreement, but only if such a third party or target business has not executed a waiver of all rights to seek access to the
Trust Account. |
| ● | The
fact that the Sponsor may convert the Working Capital Loans into our Private Placement Warrants or our Class A ordinary shares, and convert
the Overfunding Loans into our Class A ordinary shares, which will then be exchanged for Webull Warrants and Webull Class A Ordinary
Shares, respectively, upon the consummation of the Business Combination. As of the date of this Quarterly Report on Form 10-Q,
an aggregate of $5,240,000 Overfunding Loans and an aggregate of $1,280,000 Working Capital Loans have been extended by the Sponsor to
us. |
| ● | The fact that the Business Combination Agreement provides
for the continued indemnification of our current directors and officers and the continuation of directors and officers liability insurance
covering our current directors and officers. |
| ● | The fact that we shall have the right to designate one board
observer to the board of directors of Webull immediately following the Closing. |
| ● | The fact that the initial shareholders will enter into the
Registration Rights Agreement at the Closing, which provides for registration rights following consummation of the Business Combination. |
| ● | The fact that under the Sponsor Support Agreement, the initial
shareholders are entitled to a general indemnity for Webull to indemnify the Sponsor and the other shareholders for any taxes arising
from or attributable to failure of the Mergers to qualify for the Intended Tax Treatment. |
| ● | The fact that in addition to these interests of the Sponsor
and our officers, directors and advisors, to the fullest extent permitted by applicable laws and our memorandum and articles of association,
waive certain applications of the doctrine of corporate opportunity in some circumstances where the application of any such doctrine
would conflict with any fiduciary duties or contractual obligations they may have, and we will renounce any expectancy that any of our
directors or officers will offer any such corporate opportunity of which he or she may become aware to us. We do not believe that
the pre-existing fiduciary duties or contractual obligations of its officers and directors materially impacted its search for an acquisition
target. Further, we do not believe that the waiver of the application of the corporate opportunity doctrine had any impact on its search
for a potential business combination target. |
The personal and financial interests of our directors
and officers may have influenced their motivation in identifying and selecting Webull as a business combination target, completing an
initial business combination with Webull and influencing the operation of the business following the initial business combination.
There is no assurance when or if the Business Combination will
be completed.
The completion of the Business
Combination is subject to the satisfaction or waiver of a number of conditions as set forth in the Business Combination Agreement, including,
among others, (i) approval of the Business Combination by the our shareholders and the Webull shareholders; (ii) effectiveness of
the proxy statement/prospectus in connection with the Business Combination; (iii) receipt of approval for listing on the Nasdaq of
Webull Class A Ordinary Shares and each redeemable warrant to purchase one Webull Class A Ordinary Share pursuant to the terms
of the Incentive Warrant Agreement, in each case issued by Webull at the Closing to each of non-redeeming shareholders to be issued in
connection with the Transactions, subject only to official notice of issuance thereof; (iv) no governmental authority having enacted,
issued, promulgated, enforced or entered any law (whether temporary, preliminary or permanent) or governmental order that is then in effect
and which has the effect of making the Closing illegal or which otherwise prevents or prohibits consummation of the Closing (any of the
foregoing, a “restraint”), other than any such restraint that is immaterial, and all regulatory approvals required in connection
with the Business Combination have been obtained from or waived by the relevant governmental authority; (v) the expiration or early
termination of the waiting periods (and any extensions thereof) applicable to the consummation of the Transactions under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended; and (vi) the completion of the Company Capital Restructuring (as defined in the Business
Combination Agreement).
In addition to the conditions listed above, because
completion of the Business Combination will result in Mr. Anquan Wang controlling more than 25% of Webull’s total voting power,
FINRA considers the Business Combination to constitute a change of control of Webull Financial LLC (“Webull Financial”) under
Financial Industry Regulatory Authority (“FINRA”) Rule 1017. Webull Financial has submitted a continuing membership application
to FINRA relating to the Business Combination, and FINRA notified Webull Financial that it received the complete application on May 7,
2024.
No assurance can be given that the required consents,
orders and approvals will be obtained or that the required conditions to the completion of the Business Combination will be satisfied.
Even if all such consents, orders and approvals are obtained and such conditions are satisfied, no assurance can be given as to the terms,
conditions and timing of such consents, orders and approvals. We cannot provide assurance that the Business Combination will be completed
on the terms or timeline currently contemplated, or at all.
Our extraordinary shareholder meeting may take place before all of
the required regulatory approvals have been obtained and before all conditions to such approvals, if any, are known. Notwithstanding the
foregoing, if the proposal to conduct the Business Combination and the Mergers are approved by our shareholders, we would not be required
to seek further approval of our shareholders, even if the conditions imposed in obtaining required regulatory approvals could have an
adverse effect on us or Webull.
The approval of, or submission of filings with, the China Securities
Regulatory Commission, or the CSRC, may be required in connection with the Business Combination.
The People’s Republic of China (“PRC”)
government has expanded oversight over offerings that are conducted overseas by China-based issuers and foreign investment in China-based
issuers in recent years. On February 17, 2023, the CSRC released the Trial Administrative Measures of Overseas Securities Offering
and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines, which came into effect on March 31, 2023.
According to the Trial Measures, domestic companies that seek to offer or list securities overseas, both directly and indirectly, should
fulfill certain filing procedures and report relevant information to the CSRC. If the issuer meets both of the following conditions,
an overseas offering and listing will be determined as an indirect overseas offering and listing by a domestic company: (i) any of
the total assets, net assets, revenue or profits of the PRC-incorporated operating entities of the issuer in the most recent accounting
year accounts for more than 50% of the corresponding figure in the issuer’s audited consolidated financial statements for the same
period, and (ii) the issuer’s major operational activities are carried out in the PRC or its main places of business are located
in the PRC, or the senior managers in charge of operation and management of the issuer are mostly PRC citizens or are domiciled in the
PRC. The determination as to whether or not an overseas offering and listing by domestic companies is indirect, shall be made on
a substance over form basis.
Based on the advice of Webull’s PRC legal
counsel, Han Kun Law Offices, and the laws of mainland China that are currently in effect, Webull believes that this Business Combination
and Webull’s proposed listing on Nasdaq shall not be deemed as a domestic enterprise that indirectly offer or list securities on
an overseas stock exchange and therefore does not require filing or approvals from the CSRC. This determination is made on the basis
that (i) in 2022, none of the total assets, net assets, revenue or profits of Webull’s subsidiaries in China accounted for
more than 50% of the corresponding figure in Webull’s audited consolidated financial statements in 2022, and Webull expects the
same to be true for 2023; (ii) Webull primarily conducts its business in the United States and except for a research and development
center mainly responsible for technical and other support services, does not have any operation in the PRC; and (iii) most senior
managers in charge of operation and management of Webull are not PRC citizens and are not domiciled in the PRC. However, given that the
Trial Measures were recently promulgated, there remains uncertainties as to their interpretation, application, and enforcement. As advised
by Webull’s PRC legal counsel, Han Kun Law Offices, Webull has voluntarily submitted filing application documents according to the
Trial Measures and relevant supporting guidelines. Because of the voluntary nature of the CSRC application, approval is not a condition
to closing under the Business Combination Agreement.
It is uncertain whether Webull is required to, or
will be able to, or how long it will take it to, obtain such approval or complete the filing procedures. Further, the CSRC could rescind
its approval after giving it. Any failure to obtain or delay in obtaining clearance of such approval or completing such filing procedures
for this Business Combination or Webull’s proposed listing on Nasdaq, or a rescission of any such approval obtained by Webull, would
subject Webull to regulatory actions or other sanctions by the CSRC or other PRC regulatory authorities for failure to obtain required
governmental authorization. These governmental authorities may impose fines, restrictions and penalties on Webull, which might make it
advisable for Webull to suspend the Business Combination or Webull’s proposed listing on Nasdaq.
All of these could have a material adverse effect
on the trading price of Webull’s securities and could significantly limit or completely hinder Webull’s ability and the ability
of any holder of Webull’s securities to offer or continue to offer such securities.
There is no assurance if any PIPE financing as contemplated in
the Business Combination can be completed.
We
have agreed with Webull to use commercially reasonable efforts to obtain PIPE financing from third-party investors and to consummate the
PIPE Investment substantially concurrently with the closing of the Business Combination. Receipt of such PIPE financing is not a closing
condition to the Business Combination Agreement. Although we will continue to work toward obtaining the PIPE financing on market terms,
no subscription agreements have been entered into as of the date of this Quarterly Report on Form 10-Q. Accordingly, there are substantial
uncertainties with respect to the financing amount, terms and timing of PIPE financing, as well as the dilutive effect of such PIPE financing
to our non-redeeming shareholders. Furthermore, there can be no assurances that such PIPE financing can be secured at all. Lack of PIPE
financing may cause the Business Combination to become less attractive to some investors, which may make it more difficult for
us to complete the Business Combination.
If the Business Combination does not qualify as a “Reorganization”
within the meaning of Section 368(a) of the Code or as part of an “Exchange” within the meaning of Section 351(a) of
the Code, then the Business Combination generally will be taxable to U.S. Holders.
To qualify as a Reorganization, the Business Combination
must satisfy certain requirements, some of which are based on factual determinations, and actions or events after the Business Combination
could adversely affect such qualification. For example, under the continuity of business enterprise requirement under U.S. Treasury
Regulations Section 1.368-1(d), the acquiring corporation must either directly or indirectly through certain controlled corporations,
either continue a significant line of the acquired corporation’s historic business or use a significant portion of the acquired
corporation’s historic business assets in a business. However, there is an absence of guidance bearing directly on how these rules
would apply in the case of an acquisition of a corporation with only investment-type assets, such as us, or how redemptions by us, including
prior to the date of signing the Business Combination Agreement, would impact this analysis. Moreover, for the Business Combination to
qualify as a Reorganization, it is necessary that a substantial part of the value of our proprietary interests be preserved in the Business
Combination. If a significant number of our shareholders decide to redeem their Public Shares, this requirement may not be satisfied,
in which case the Business Combination may not qualify as a Reorganization. Because the qualification of the Business Combination as a
Reorganization is based on certain facts that will not be known until or following the Closing and the legal uncertainties described above,
the qualification of the Business Combination as a Reorganization is subject to significant uncertainty, and is therefore not capable
of being the subject of a representation regarding its tax treatment. In addition, neither us nor Webull intends to request a ruling from
the IRS regarding the U.S. federal income tax treatment of the Business Combination. Accordingly, no assurance can be given that
the Business Combination will qualify as a Reorganization, that the IRS will not challenge the Business Combination’s qualification
as a Reorganization or that a court will not sustain such a challenge by the IRS.
Even if the Business Combination does not qualify
as a Reorganization, the parties intend to take the position that the Business Combination, together with the Conversion, qualify as an
exchange described in Section 351(a) of the Code (an “Exchange”). However, there is a lack of authority supporting
the treatment of the Business Combination, together with the Conversion, as an Exchange, and accordingly there is significant uncertainty
that the Business Combination would so qualify. Neither us nor Webull intends to request a ruling from the IRS regarding the U.S. federal
income tax treatment of the Business Combination as part of an Exchange, and no assurance can be given that Business Combination will
qualify as part of an Exchange, that the IRS will not challenge this position or that a court will not sustain such a challenge by the
IRS. Further, the Closing is not conditioned upon the receipt of an opinion of counsel that the Mergers will qualify as a Reorganization
and/or as part of an Exchange.
If the Business Combination does not qualify as
a Reorganization or as part of an Exchange, then a U.S. Holder generally will recognize gain or loss in an amount equal to the difference
between the fair market value (as of the Closing Date of the Business Combination) of Webull Class A Ordinary Shares, Webull Warrants
and/or Incentive Warrants received in the Business Combination, over such holder’s aggregate adjusted tax basis in the corresponding
Public Shares and Public Warrants surrendered by such holder in the Business Combination. Even if the Business Combination otherwise qualifies
as a Reorganization or part of an Exchange, U.S. Holders may be required to recognize gain (but not loss) in the Business Combination
under the PFIC rules. The tax consequences of the Business Combination are complex and will depend on each U.S. Holder’s particular
circumstances.
We may not have sufficient funds to consummate the Business Combination.
As of December 31, 2023, we had US$163,718 of cash
held outside the Trust Account. If we are required to seek additional capital, we may need to borrow funds from the Sponsor, directors,
officers, their affiliates or other third parties to operate or may be forced to liquidate. We believe that the funds available to us
outside of the Trust Account, together with funds available from loans from Sponsor, its affiliates or members of our management team
will be sufficient to allow us to operate for at least the period ending on September 30, 2024 (or March 31, 2025 as may be approved
in accordance with an amended and restated memorandum and articles of association); however, we cannot assure you that its estimate is
accurate, and the Sponsor, directors, officers and their affiliates are under no obligation to advance funds to us in such circumstances.
Our management concluded that there is substantial doubt about
its ability to continue as a “going concern.”
As of December 31, 2023, we had $163,718 in its operating bank accounts
and $109,573,279 in marketable securities held in the Trust Account to be used for a business combination or to repurchase or redeem our
ordinary shares in connection therewith. If we are unable to raise additional funds to alleviate liquidity needs and complete a business
combination by September 30, 2024 (or March 31, 2025 as may be approved in accordance with an amended and restated memorandum and articles
of association), we will cease all operations except for the purpose of liquidating. The liquidity condition and date for mandatory liquidation
and subsequent dissolution raise substantial doubt about our ability to continue as a going concern.
We depend on a variety of U.S. and multi-national financial institutions
to provide us with banking services. The default or failure of one or more of the financial institutions that we rely on may adversely
affect our business and financial condition.
We maintain the majority of
our cash and cash equivalents in accounts with major U.S. and multi-national financial institutions, and our deposits at certain of these
institutions exceed insured limits. Market conditions can impact the viability of these institutions. In the event of the failure of any
of the financial institutions where we maintain our cash and cash equivalents, there can be no assurance that we would be able to access
uninsured funds in a timely manner or at all. Any inability to access or delay in accessing these funds could adversely affect our liquidity,
business and financial condition.
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Unregistered Sales of Equity Securities
We have not sold any equity securities during the
quarter ended March 31, 2024.
Use of Proceeds
In connection with the Initial Public Offering
and the Partial Over-Allotment Exercise, we incurred offering costs of approximately $12.6 million (including deferred underwriting commissions
of approximately $7.3 million). Other incurred offering costs consisted principally of preparation fees related to the Initial Public
Offering. After deducting the underwriting discounts and commissions (excluding the deferred portion, which amount will be payable upon
consummation of the initial Business Combination, if consummated) and the Initial Public Offering expenses, approximately $214.8 million
of the net proceeds of the Initial Public Offering, the Partial Over-Allotment Exercise, the proceeds of the Overfunding Loans and certain
of the proceeds of the Private Placement and the Additional Private Placement was placed in the Trust Account. The net proceeds of the
Initial Public Offering, the Partial Over-Allotment Exercise, the proceeds of the Overfunding
Loans and certain of the proceeds of the Private Placement and the Additional Private Placement are held in the Trust Account and invested
as described elsewhere in this Quarterly Report on Form 10-Q.
There has been no material change in the planned
use of the proceeds from the Initial Public Offering, the Overfunding Loan and the Private
Placement as is described in the Company’s final prospectus related to the Initial Public Offering.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM
5. OTHER INFORMATION
No officers or directors, as defined in Rule 16a-1(f), adopted and/or
terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation
S-K Item 408, during the last fiscal quarter.
ITEM
6. EXHIBITS
The following exhibits are filed as part of, or incorporated by reference
into, this Quarterly Report on Form 10-Q.
|
|
|
|
Incorporation by Reference |
Exhibit No. |
|
Description |
|
Form |
|
File No. |
|
Exhibit |
|
Filing Date |
2.1 |
|
Business Combination Agreement, dated as of February 27, 2024, by and among the Company, Webull, Merger Sub I and Merger Sub II |
|
8-K |
|
001-41432 |
|
2.1 |
|
February 28, 2024 |
10.1 |
|
Sponsor Support Agreement, dated as of February 27, 2024, by and among SPAC, Sponsor, Webull and SPAC Insiders |
|
8-K |
|
001-41432 |
|
10.1 |
|
February 28, 2024 |
10.2 |
|
Form of Shareholder Lock-up Agreement, by and among SPAC, Webull and certain shareholders of Webull |
|
8-K |
|
001-41432 |
|
10.2 |
|
February 28, 2024 |
10.3 |
|
Form of Registration Rights Agreement, by and among SPAC, Sponsor, Webull and certain shareholders of Webull |
|
8-K |
|
001-41432 |
|
10.3 |
|
February 28, 2024 |
10.4 |
|
Form of Warrant Assignment Agreement, by and among SPAC, Webull and Warrant Agent |
|
8-K |
|
001-41432 |
|
10.4 |
|
February 28, 2024 |
10.5 |
|
Form of Incentive Warrant Agreement, by and between Webull and Warrant Agent |
|
8-K |
|
001-41432 |
|
10.5 |
|
February 28, 2024 |
31.1 |
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
|
31.2 |
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
|
32.1* |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
|
32.2* |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
|
101.INS |
|
Inline XBRL Instance Document. |
|
|
|
|
|
|
|
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document. |
|
|
|
|
|
|
|
|
101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
|
|
|
|
|
|
|
|
101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document. |
|
|
|
|
|
|
|
|
101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document. |
|
|
|
|
|
|
|
|
101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
|
|
|
|
|
|
|
|
104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
|
|
| * | These certifications are furnished to the SEC pursuant to Section
906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly
set forth by specific reference in such filing. |
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
SK GROWTH OPPORTUNITIES CORPORATION |
|
|
|
|
Date: May 15, 2024 |
By: |
/s/ Richard Chin |
|
|
Name: |
Richard Chin |
|
|
Title: |
Chief Executive Officer |
Date: May 15, 2024 |
By: |
/s/ Derek Jensen |
|
|
Name: |
Derek Jensen |
|
|
Title: |
Chief Financial Officer |
34
10056597
20960000
0.01
0.08
5240000
5240000
0.01
0.08
P185D
10056597
20960000
5240000
5240000
0.01
0.01
0.08
0.08
P185D
0.5
P5Y
P30D
false
--12-31
Q1
0001912461
0001912461
2024-01-01
2024-03-31
0001912461
skgr:UnitsEachConsistingOfOneClassAOrdinaryShare00001ParValueAndOnehalfOfOneRedeemableWarrantMember
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassAMember
2024-01-01
2024-03-31
0001912461
skgr:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassAMember
2024-05-15
0001912461
us-gaap:CommonClassBMember
2024-05-15
0001912461
2024-03-31
0001912461
2023-12-31
0001912461
us-gaap:CommonClassAMember
2024-03-31
0001912461
us-gaap:CommonClassAMember
2023-12-31
0001912461
us-gaap:CommonClassBMember
2024-03-31
0001912461
us-gaap:CommonClassBMember
2023-12-31
0001912461
2023-01-01
2023-03-31
0001912461
us-gaap:CommonClassAMember
2023-01-01
2023-03-31
0001912461
us-gaap:CommonClassBMember
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassBMember
2023-01-01
2023-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-12-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001912461
us-gaap:RetainedEarningsMember
2023-12-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001912461
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001912461
us-gaap:RetainedEarningsMember
2024-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001912461
us-gaap:RetainedEarningsMember
2022-12-31
0001912461
2022-12-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001912461
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001912461
us-gaap:RetainedEarningsMember
2023-03-31
0001912461
2023-03-31
0001912461
us-gaap:IPOMember
2022-06-28
2022-06-28
0001912461
us-gaap:IPOMember
2022-06-28
0001912461
2022-06-28
0001912461
2022-06-28
2022-06-28
0001912461
us-gaap:OverAllotmentOptionMember
2022-06-28
2022-06-28
0001912461
us-gaap:OverAllotmentOptionMember
2022-06-28
0001912461
skgr:PartialOverallotmentExerciseMember
2022-07-20
2022-07-20
0001912461
skgr:PartialOverallotmentExerciseMember
2022-07-20
0001912461
us-gaap:CommonClassBMember
2022-08-09
2022-08-09
0001912461
skgr:PrivatePlacementWarrantsMember
skgr:SponsorMember
2024-01-01
2024-03-31
0001912461
skgr:PrivatePlacementWarrantsMember
skgr:SponsorMember
2024-03-31
0001912461
skgr:AdditionalPrivatePlacementWarrantsMember
skgr:SponsorMember
2024-01-01
2024-03-31
0001912461
skgr:AdditionalPrivatePlacementWarrantsMember
skgr:SponsorMember
2024-03-31
0001912461
skgr:FirstoverfundingLoanMember
2022-06-28
0001912461
skgr:SecondOverfundingLoanMember
2022-06-28
0001912461
skgr:PublicShareholdersMember
2024-03-31
0001912461
skgr:TrustAccountMember
2024-03-31
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2024-01-01
2024-03-31
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2024-01-01
2024-03-31
0001912461
skgr:WorkingCapitalLoanMember
skgr:SponsorMember
2024-03-31
0001912461
skgr:UnsecuredPromissoryNoteMember
skgr:SponsorMember
2023-10-30
2023-10-30
0001912461
skgr:UnsecuredPromissoryNoteMember
2023-10-30
0001912461
skgr:SponsorNoteMember
2024-03-01
0001912461
skgr:SponsorNoteMember
skgr:SponsorMember
2024-03-01
0001912461
skgr:SponsorMember
2024-03-01
0001912461
us-gaap:OverAllotmentOptionMember
2022-08-09
2022-08-09
0001912461
skgr:ClassAOrdinarySharesSubjectToPossibleRedemptionMember
2024-03-31
0001912461
skgr:ClassAOrdinarySharesSubjectToPossibleRedemptionMember
2023-12-31
0001912461
us-gaap:WarrantMember
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassAMember
2022-01-01
2022-12-31
0001912461
us-gaap:CommonClassAMember
2022-12-31
0001912461
us-gaap:CommonClassAMember
2023-01-01
2023-12-31
0001912461
skgr:UnderwriterMember
2022-07-20
0001912461
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2024-03-31
0001912461
skgr:PublicWarrantsMember
2024-03-31
0001912461
skgr:PublicWarrantsMember
us-gaap:CommonClassAMember
2024-03-31
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2021-12-09
2021-12-09
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2021-12-09
0001912461
us-gaap:CommonClassBMember
2022-02-24
2022-02-24
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
skgr:FounderSharesMember
2022-05-05
2022-05-05
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
skgr:FounderSharesMember
2022-05-05
0001912461
skgr:SponsorMember
skgr:FounderSharesMember
2024-03-31
0001912461
skgr:SponsorMember
us-gaap:CommonClassAMember
2024-03-31
0001912461
skgr:IndependentDirectorNomineesMember
skgr:SponsorMember
us-gaap:CommonClassBMember
2022-02-01
2022-03-31
0001912461
skgr:PrivatePlacementWarrantsMember
skgr:SponsorMember
us-gaap:OverAllotmentOptionMember
2024-03-31
0001912461
skgr:PrivatePlacementWarrantsMember
2024-01-01
2024-03-31
0001912461
skgr:SponsorMember
2024-01-01
2024-03-31
0001912461
skgr:OverfundingLoansMember
skgr:SponsorMember
2022-06-28
0001912461
skgr:OverfundingLoansMember
skgr:SponsorMember
us-gaap:OverAllotmentOptionMember
2022-07-20
0001912461
skgr:OverfundingLoansMember
skgr:SponsorMember
us-gaap:CommonClassAMember
2024-03-31
0001912461
skgr:WorkingCapitalLoanMember
skgr:SponsorMember
2024-03-31
0001912461
skgr:WorkingCapitalLoanMember
skgr:SponsorMember
2023-12-31
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2023-10-30
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2023-10-30
2023-10-30
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2024-03-01
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2024-03-01
2024-03-01
0001912461
skgr:PromissoryNoteMember
2024-03-01
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2024-03-31
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
us-gaap:CommonClassAMember
2024-03-31
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2023-12-31
0001912461
skgr:ExtensionLoansMember
skgr:SponsorMember
2024-03-31
0001912461
skgr:BusinessCombinationMember
skgr:ExtensionLoansMember
skgr:SponsorMember
2024-03-31
0001912461
skgr:ExtensionLoansMember
2024-03-31
0001912461
skgr:ExtensionLoansMember
2023-12-31
0001912461
skgr:SecretarialAndAdministrationSupportServicesMember
skgr:AffiliateOfSponsorMember
2022-06-23
2022-06-23
0001912461
skgr:AdministrationAndSupportServicesMember
skgr:SponsorMember
2024-01-01
2024-03-31
0001912461
skgr:AdministrationAndSupportServicesMember
skgr:SponsorMember
2023-01-01
2023-03-31
0001912461
us-gaap:IPOMember
2024-01-01
2024-03-31
0001912461
2022-07-20
2022-07-20
0001912461
skgr:UnderwriterMember
2024-03-31
0001912461
us-gaap:InvestorMember
us-gaap:CommonClassAMember
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-03-31
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2024-01-01
2024-03-31
0001912461
us-gaap:MeasurementInputSharePriceMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
us-gaap:MeasurementInputExpectedTermMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
skgr:ClassAOrdinarySubjectToPossibleRedemptionMember
2023-12-31
0001912461
skgr:ClassAOrdinarySubjectToPossibleRedemptionMember
2024-03-31
0001912461
us-gaap:CommonClassBMember
2022-12-31
0001912461
us-gaap:CommonClassBMember
skgr:FounderSharesMember
2023-12-31
0001912461
us-gaap:OverAllotmentOptionMember
2022-07-20
2022-07-20
0001912461
us-gaap:CommonClassBMember
skgr:FounderSharesMember
2024-01-01
2024-03-31
0001912461
skgr:PublicWarrantsMember
2023-12-31
0001912461
skgr:PrivatePlacementWarrantsMember
2023-12-31
0001912461
skgr:PrivatePlacementWarrantsMember
2024-03-31
0001912461
skgr:PublicWarrantsMember
2024-01-01
2024-03-31
0001912461
skgr:PublicWarrantsMember
us-gaap:CommonClassAMember
2024-01-01
2024-03-31
0001912461
2023-01-01
2023-12-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2024-03-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2024-03-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2024-03-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly Report of SK Growth Opportunities
Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Richard Chin, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) the Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.
In connection with the Quarterly Report of SK Growth Opportunities
Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Derek Jensen, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) the Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.